Acyclovir for infants

and herpes zoster infection. Acyclovir and valacyclovir. Acyclovir has been well studied in infants and children and is most often the

Over all, acyclovir is a safe and effective drug with acyclovir-resistant HSV in an infant on long term suppressive acyclovir therapy.

The levels of acyclovir in amniotic fluid can be similar to those seen in infants treated with systemic acyclovir, and neutropenia develops in up to 20% of such infants. 33 Although a

birth defects in over 1,500 infants exposed to acyclovir and over 200 infants exposed to valacyclovir during the first trimester of pregnancy. Does taking acyclovir/valacyclovir in pregnancy increase the chance of other pregnancy-related problems?

birth defects in over 1,500 infants exposed to acyclovir and over 200 infants exposed to valacyclovir during the first trimester of pregnancy. Does taking acyclovir/valacyclovir in pregnancy increase the chance of other pregnancy-related problems?

Even with the highest maternal dosages, the dosage of acyclovir in milk is only about 1% of a typical infant dosage and would not be expected to cause any adverse effects in breastfed infants. Topical acyclovir applied to small areas of the mother's body away from the breast should pose no risk to the infant.

If the infant remains asymptomatic, a preemptive 10-day course of acyclovir should be completed. If at any time the infant becomes symptomatic, then treat as previously described with acyclovir for 14 to 21 days depending on type of disease.

Asymptomatic infant with Negative Studies. For asymptomatic infants whose HSV tests remain negative, acyclovir may be discontinued unless

Acyclovir was well tolerated in an open-label PTN study of 32 infants recently completed ( An Open Label Study to Describe the Pharmacokinetics of Acyclovir in Premature Infants ; Investigational New Drug application [IND] 106,153) . The cohort represented a group of critically ill infants.